GeneReach Biotechnology Corp. (TPEX:4171)

Market Cap	1.18B -27.5%
Revenue (ttm)	215.32M +4.3%
Net Income	-148.46M
EPS	-2.60
Shares Out	57.70M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	99,550
Average Volume	497,559
Open	20.45
Previous Close	20.80
Day's Range	20.40 - 20.75
52-Week Range	15.40 - 29.40
Beta	0.58
RSI	46.50
Earnings Date	Mar 27, 2026

About GeneReach Biotechnology

GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers various equipment, such as POCKIT Central Nucleic Acid Analyzer, POCKIT Micro Series, taco mini Automatic Nucleic Acid Extraction System, taco Prep Homogenization System, and cubee Mini-Centrifuge; reagents and consumables, including Human IVD Assays, iiPCR Specific Reagents, research reagents and consumables, as well as taco Nucleic Acid Extraction Reagents, IQ REAL Quantitative System, and IQ20...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4171

Financial Performance

In 2024, GeneReach Biotechnology's revenue was 206.49 million, a decrease of -8.41% compared to the previous year's 225.46 million. Losses were -118.73 million, -28.59% less than in 2023.